J. Watson

发表

Measurement of Oncoproteins Simultaneously with DNA in Individual Cells Using Flow Cytometry

J. Watson, 1989 .

Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis.

B. Wilson, G. Evan, D. Wight, 1987, Journal of clinical pathology.

Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia.

G. Evan, H. Cox, J. Watson, 1987, British Journal of Cancer.

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma.

W. Lewin, N. Bleehen, C. Wiltshire, 1981, British Journal of Cancer.

Effects of x-radiation on the spinal cord: an experimental study of the morphological changes in central nerve fibres.

F. Mastaglia, W. Mcdonald, J. Watson, 1976, Brain : a journal of neurology.

Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor

J. Shepherd, J. Watson, D. Lowe, 2022 .

Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer.

C. Hudson, S. Stenning, J. Watson, 1998, Journal of clinical pathology.

Neuron specific enolase expression in carcinoma of the lung.

N. Bleehen, J. Stewart, P. Twentyman, 1986, British Journal of Cancer.

Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells

S. Powers, K. Nguyen, S. Elliott, 2008, British Journal of Cancer.

Clinical studies with misonidazole.

N. Bleehen, P. Workman, C. Wiltshire, 1978, The British journal of cancer. Supplement.

Oestrogen potentiates topoisomerase‐II‐mediated cytotoxicity in an activated subpopulation of human breast cancer cells: Implications for cytotoxic drug resistance in solid tumours

N. Bleehen, P. Smith, J. Watson, 1989, International journal of cancer.

c‐myc protein product is a marker of DNA synthesis but not of malignancy in human gastrointestinal tissues and tumours

D. Rew, G. Wilson, G. Wilson, 1991, The British journal of surgery.

The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer.

J. Stewart, G. Evan, K. Sikora, 1986, British Journal of Cancer.

A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded material.

G. Evan, K. Sikora, J. Watson, 1985, Journal of immunological methods.

Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer.

C. Hudson, J. Watson, O. M. Curling, 1987, Gynecologic oncology.

Cervical brush biopsy specimens suitable for DNA and oncoprotein analysis using flow cytometry.

G. Evan, H. Cox, J. Watson, 1986, Journal of Clinical Pathology.

cytometry . oncoprotein analysis using flow specimens suitable for DNA and Cervical brush biopsy

G. Evan, H. Cox, J. Watson, 2022 .

Prolonged observations on variations in the serum copper in Hodgkin's disease.

J. Watson, A. Jelliffe, C. Hobbs, 1969, Clinical radiology.

CHANGES IN CELL PROLIFERATION KINETICS OCCURRING DURING THE LIFE HISTORY OF MONOLAYER CULTURES OF A MOUSE TUMOUR CELL LINE

N. Bleehen, N. Bleehen, J. Watson, 1975, Cell and tissue kinetics.

Flow cytometric DNA analysis in gynecological oncology

P. V. van Dam, D. Lowe, J. Shepherd, 1991, International Journal of Gynecologic Cancer.

Establishment and characterisation of cell lines from patients with lung cancer (predominantly small cell carcinoma).

N. Bleehen, P. Workman, N. Fox, 1985, British Journal of Cancer.

What does "response" in cancer chemotherapy really mean?

J. Watson, 1981, British medical journal.

Multiparameter flow cytometric analysis of a novel cytotoxin (factor 2) induced tumor cell membrane permeability.

A. Karpas, J. Ni, H. Cox, 1993, Cytometry.

A linear transform of the multi-target survival curve.

J. Watson, 1978, The British journal of radiology.

Flow cytometric and immunohistochemical analysis of p62c-myc oncoprotein in the bronchial epithelium of lung cancer patients.

N. Bleehen, B. Wilson, V. Sundaresan, 1991, Anticancer research.

Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.

N. Bleehen, J. Watson, S. H. Chambers, 1984, British Journal of Cancer.

Intracranial Hodgkin's disease: a primary presentation and access of cytotoxic agents.

M. Ashby, J. Watson, D. Bowen, 1986, British Journal of Radiology.

Scheduled and unscheduled combination chemotherapy in the treatment of squamous cell lung cancer (cyclophosphamide, adriamycin, vincristine and bleomycin, with and without cis-platinum).

K. Sikora, N. Bleehen, R. Grant, 1983, Anticancer Research.

Multiparameter flow cytometric measurement of epidermal growth factor receptor and c‐erbB‐2 oncoprotein in cultured cells and in fresh and preserved solid tumor cells

P. V. van Dam, D. Lowe, J. Shepherd, 1995, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Etoposide-induced cell cycle delay and arrest-dependent modulation of DNA topoisomerase II in small-cell lung cancer cells.

N. Bleehen, N. Bleehen, T. Gottlieb, 1994, British Journal of Cancer.

c-myc oncoprotein levels in bladder cancer

G. Evan, J. Watson, S. Vesey, 2004, Urological Research.